Clinical trials
Carcinoma, Ovarian Epithelial trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lei Li | 12 |
| Peking Union Medical College Hospital | 2 |
| RenJi Hospital | 2 |
| Xiaoxiang Chen | 2 |
| Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 1 |
| CAI Hongbing | 1 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 1 |
| Hebei Medical University Fourth Hospital | 1 |
| Lee's Pharmaceutical Limited | 1 |
| Multitude Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 34 |
| Ovarian Neoplasms | 8 |
| Fallopian Tube Neoplasms | 7 |
| Carcinoma | 3 |
| Neoplasms | 3 |
| Adnexal Diseases | 2 |
| Genital Diseases, Female | 2 |
| Genital Neoplasms, Female | 2 |
| Neoplasms by Histologic Type | 2 |
| Neoplasms by Site | 2 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.